SavedAdd your journal

Journals / Journal of Experimental and Clinical Medicine / 2022 / Cilt: 39 - Sayı: 1

Acute motor axonal neuropathy associated with COVID-19

Mehlika PANPALLI ATEŞ
Beyza CETİN
Beria ERTUGRUL
Ahmet YUKSEKTEPE
Selim COMOGLU
Pages
277–279
Publication Date
2022-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result of the patient's neurological examination, acute motor axonal neuropathy (AMAN) was diagnosed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:COVID-19, which is considered a global pandemic, is constantly being renewed.
📊
Key Findings & Data:This article presents a 69-year-old female patient diagnosed with AMAN due to a COVID-19 infection.
💡
Conclusion & Impact:As a result of the patient's neurological examination, acute motor axonal neuropathy (AMAN) was diagnosed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Acute motor axonal neuropathy · Covid-19 · Guillain-Barré syndrome

Abstract

COVID-19, which is considered a global pandemic, is constantly being renewed. Acute motor axonal neuropathy (AMAN) is a rare, axonal variant of Guillain-Barré syndrome (GBS). This article presents a 69-year-old female patient diagnosed with AMAN due to a COVID-19 infection. Sixty-nine-year-old female patient who started myalgia, headache, cough 14 days ago, and was added diarrhea, fever, loss of smell and taste. Nasopharyngeal SARS-CoV-2 polymerase chain reaction (PCR) was found to be positive. Ten days later, numbness and weakness developed in the distal extremities. As a result of the patient's neurological examination, acute motor axonal neuropathy (AMAN) was diagnosed.

🔖

Cite This Article

ATEŞ, M. P., CETİN, B., ERTUGRUL, B., YUKSEKTEPE, A., COMOGLU, S. (2022). Acute motor axonal neuropathy associated with COVID-19. Journal of Experimental and Clinical Medicine, Cilt: 39 - Sayı: 1, 277–279. https://ajindex.com/articles/677795

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID-19–associated Guillain-Barré syndrome: The early pandemic experience. Muscle & Nerve. 2020; 62: 485–491. doi: 10.1002/mus.27024
  2. Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. 2020; 41: 3149–3156
  3. Parsamanesh N, Pezeshgi A, Hemmati M, Jameshorani M, Saboory E. Neurological manifestations of coronavirus infections: role of angiotensin-converting enzyme 2 in COVID-19. Int J Neurosci. 2021:1-8. doi: 10.1080/00207454.2020.1849193
  4. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683-690. doi: 10.1001/jamaneurol.2020.1127
  5. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020; 382(23): 2268-2270. doi: 10.1056/NEJMc2008597
  6. Scheidl E, Canseco DD, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literatüre. J Peripher Nerv Syst. 2020; 1-4. doi: 10.1111/jns.12382
  7. Ates MP, Dibek DM, Guven H, Comoglu SS. A Rare Complication of Bariatric Surgery; Guillain Barre Syndrome. J Clin Images. 2020; 3(1): 1051. doi: 10.33582/2690-8662/1051
  8. Panpalli Ates M, Guven H, Comoglu SS. Temporary conduction block in acute motor axonal neuropathy. Acta Neurol Belg. 2016; 116(3): 425-427. doi: 10.1007/s13760-015-0543-8
  9. Paybast S, Gorji R, Mavandadi S. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and Review of the Literature. Neurologist. 2020; 25(4): 101-103. doi: 10.1097/NRL.0000000000000291
  10. Dalakas MC. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm. 2020; 7(5): e781. doi:10.1212/NXI.0000000000000781